Your browser doesn't support javascript.
loading
Netrin-1 promotes naive pluripotency through Neo1 and Unc5b co-regulation of Wnt and MAPK signalling.
Huyghe, Aurélia; Furlan, Giacomo; Ozmadenci, Duygu; Galonska, Christina; Charlton, Jocelyn; Gaume, Xavier; Combémorel, Noémie; Riemenschneider, Christina; Allègre, Nicolas; Zhang, Jenny; Wajda, Pauline; Rama, Nicolas; Vieugué, Pauline; Durand, Isabelle; Brevet, Marie; Gadot, Nicolas; Imhof, Thomas; Merrill, Bradley J; Koch, Manuel; Mehlen, Patrick; Chazaud, Claire; Meissner, Alexander; Lavial, Fabrice.
Afiliación
  • Huyghe A; Cellular Reprogramming and Oncogenesis Laboratory, Equipe labellisée la Ligue contre le cancer, Labex DEVweCAN, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon, Lyon, France.
  • Furlan G; Cellular Reprogramming and Oncogenesis Laboratory, Equipe labellisée la Ligue contre le cancer, Labex DEVweCAN, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon, Lyon, France.
  • Ozmadenci D; Cellular Reprogramming and Oncogenesis Laboratory, Equipe labellisée la Ligue contre le cancer, Labex DEVweCAN, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon, Lyon, France.
  • Galonska C; Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.
  • Charlton J; Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.
  • Gaume X; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Combémorel N; Harvard Stem Cell Institute, Cambridge, MA, USA.
  • Riemenschneider C; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
  • Allègre N; Cellular Reprogramming and Oncogenesis Laboratory, Equipe labellisée la Ligue contre le cancer, Labex DEVweCAN, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon, Lyon, France.
  • Zhang J; Cellular Reprogramming and Oncogenesis Laboratory, Equipe labellisée la Ligue contre le cancer, Labex DEVweCAN, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon, Lyon, France.
  • Wajda P; Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.
  • Rama N; GReD, Université Clermont Auvergne, CNRS, INSERM, BP38, Clermont-Ferrand, France.
  • Vieugué P; Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, IL, USA.
  • Durand I; Cellular Reprogramming and Oncogenesis Laboratory, Equipe labellisée la Ligue contre le cancer, Labex DEVweCAN, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon, Lyon, France.
  • Brevet M; Apoptosis, Cancer and Development Laboratory, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon, Lyon, France.
  • Gadot N; Apoptosis, Cancer and Development Laboratory, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon, Lyon, France.
  • Imhof T; Cytometry Facility, Université de Lyon, Université Claude Bernard Lyon 1, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon, INSERM 1052, CNRS 5286, Lyon, France.
  • Merrill BJ; Research Pathology platform, Department of translational research and innovation, Centre Léon Bérard, Lyon, France.
  • Koch M; Research Pathology platform, Department of translational research and innovation, Centre Léon Bérard, Lyon, France.
  • Mehlen P; Institute for Dental Research and Oral Musculoskeletal Research, Center for Biochemistry, University of Cologne, Cologne, Germany.
  • Chazaud C; Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, IL, USA.
  • Meissner A; Institute for Dental Research and Oral Musculoskeletal Research, Center for Biochemistry, University of Cologne, Cologne, Germany.
  • Lavial F; Apoptosis, Cancer and Development Laboratory, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon, Lyon, France.
Nat Cell Biol ; 22(4): 389-400, 2020 04.
Article en En | MEDLINE | ID: mdl-32231305
ABSTRACT
In mouse embryonic stem cells (mESCs), chemical blockade of Gsk3α/ß and Mek1/2 (2i) instructs a self-renewing ground state whose endogenous inducers are unknown. Here we show that the axon guidance cue Netrin-1 promotes naive pluripotency by triggering profound signalling, transcriptomic and epigenetic changes in mESCs. Furthermore, we demonstrate that Netrin-1 can substitute for blockade of Gsk3α/ß and Mek1/2 to sustain self-renewal of mESCs in combination with leukaemia inhibitory factor and regulates the formation of the mouse pluripotent blastocyst. Mechanistically, we reveal how Netrin-1 and the balance of its receptors Neo1 and Unc5B co-regulate Wnt and MAPK pathways in both mouse and human ESCs. Netrin-1 induces Fak kinase to inactivate Gsk3α/ß and stabilize ß-catenin while increasing the phosphatase activity of a Ppp2r2c-containing Pp2a complex to reduce Erk1/2 activity. Collectively, this work identifies Netrin-1 as a regulator of pluripotency and reveals that it mediates different effects in mESCs depending on its receptor dosage, opening perspectives for balancing self-renewal and lineage commitment.
Asunto(s)
Regulación del Desarrollo de la Expresión Génica; Proteínas del Tejido Nervioso/genética; Receptores de Netrina/genética; Netrina-1/genética; Receptores de Superficie Celular/genética; Vía de Señalización Wnt/genética; Animales; Línea Celular; Embrión de Mamíferos; Quinasas MAP Reguladas por Señal Extracelular/genética; Quinasas MAP Reguladas por Señal Extracelular/metabolismo; Quinasa 1 de Adhesión Focal/genética; Quinasa 1 de Adhesión Focal/metabolismo; Glucógeno Sintasa Quinasa 3 beta/antagonistas & inhibidores; Glucógeno Sintasa Quinasa 3 beta/genética; Glucógeno Sintasa Quinasa 3 beta/metabolismo; Humanos; Isoenzimas/antagonistas & inhibidores; Isoenzimas/genética; Isoenzimas/metabolismo; Factor Inhibidor de Leucemia/genética; Factor Inhibidor de Leucemia/metabolismo; MAP Quinasa Quinasa 1/antagonistas & inhibidores; MAP Quinasa Quinasa 1/genética; MAP Quinasa Quinasa 1/metabolismo; MAP Quinasa Quinasa 2/antagonistas & inhibidores; MAP Quinasa Quinasa 2/genética; MAP Quinasa Quinasa 2/metabolismo; Masculino; Ratones; Ratones Noqueados; Ratones SCID; Células Madre Embrionarias de Ratones/citología; Células Madre Embrionarias de Ratones/metabolismo; Proteínas del Tejido Nervioso/metabolismo; Receptores de Netrina/metabolismo; Netrina-1/metabolismo; Células Madre Pluripotentes/citología; Células Madre Pluripotentes/metabolismo; Proteína Fosfatasa 2/genética; Proteína Fosfatasa 2/metabolismo; Receptores de Superficie Celular/metabolismo; beta Catenina/genética; beta Catenina/metabolismo

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Receptores de Superficie Celular / Regulación del Desarrollo de la Expresión Génica / Vía de Señalización Wnt / Netrina-1 / Receptores de Netrina / Proteínas del Tejido Nervioso Tipo de estudio: Prognostic_studies Idioma: En Revista: Nat Cell Biol Año: 2020 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Receptores de Superficie Celular / Regulación del Desarrollo de la Expresión Génica / Vía de Señalización Wnt / Netrina-1 / Receptores de Netrina / Proteínas del Tejido Nervioso Tipo de estudio: Prognostic_studies Idioma: En Revista: Nat Cell Biol Año: 2020 Tipo del documento: Article País de afiliación: Francia